Skip to main content
. 2022 Feb 11;477(5):1381–1392. doi: 10.1007/s11010-022-04381-9

Fig. 7.

Fig. 7

Mechanism of hyperprolactinemia in Covid-19: Prolactin (PRL) increases angiotensin II (AngII), IL-1β, IL-6, and arginine vasopressin (AVP) with reduction of dopa decarboxylase (DDC), with subsequent increase of PRL